127 related articles for article (PubMed ID: 35812254)
1. Clofazimine induced pigmentation in leprosy patches.
Chavhan SD; Jawade S
Pan Afr Med J; 2022; 42():14. PubMed ID: 35812254
[No Abstract] [Full Text] [Related]
2. Skin pigmentation from clofazimine therapy in leprosy patients: a reappraisal.
Job CK; Yoder L; Jacobson RR; Hastings RC
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):236-41. PubMed ID: 2145325
[TBL] [Abstract][Full Text] [Related]
3. Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).
McDougall AC; Jones RL
J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):116-20. PubMed ID: 6260900
[TBL] [Abstract][Full Text] [Related]
4. A review of side-effects experienced by patients taking clofazimine.
Moore VJ
Lepr Rev; 1983 Dec; 54(4):327-35. PubMed ID: 6668986
[No Abstract] [Full Text] [Related]
5. [Clofazimine and the eye].
Negrel AD; Baquillon G; de La Panouse A; Ducam M; Bagadec R; Chovet M
Acta Leprol; 1981; (84):31-7. PubMed ID: 6797221
[No Abstract] [Full Text] [Related]
6. Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study.
Nogueira AS; Garcia MAC; Silva MBD; Costa PFD; Frade MAC; Salgado CG; Barreto JG
Trop Med Int Health; 2024 Apr; 29(4):327-333. PubMed ID: 38348585
[TBL] [Abstract][Full Text] [Related]
7. Image Gallery: Clofazimine-induced hyperpigmentation of leprosy plaques.
Bishnoi A; Chatterjee D; Narang T; Dogra S
Br J Dermatol; 2019 Oct; 181(4):e88. PubMed ID: 31281972
[No Abstract] [Full Text] [Related]
8. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
9. Effect of clofazimine on eye in multibacillary leprosy.
Kaur I; Ram J; Kumar B; Kaur S; Sharma VK
Indian J Lepr; 1990; 62(1):87-90. PubMed ID: 2358706
[TBL] [Abstract][Full Text] [Related]
10. Clofazimine and the eye: preliminary communication.
Nêgrel AD; Chovet M; Baquillon G; Lagadec R
Lepr Rev; 1984 Dec; 55(4):349-52. PubMed ID: 6527599
[No Abstract] [Full Text] [Related]
11. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
[TBL] [Abstract][Full Text] [Related]
12. Dermoscopic features of clofazimine-induced pigmentation in a borderline tuberculoid leprosy plaque.
Behera B; Palit A; Sethy M; Nayak AK; Dash S; Ayyanar P
Indian J Dermatol Venereol Leprol; 2021; 88(1):85-87. PubMed ID: 34491673
[No Abstract] [Full Text] [Related]
13. RED AND BLACK PIGMENTATION DEVELOPING DURING TREATMENT OF LEPROSY WITH 'B 663'.
BROWNE SG
Lepr Rev; 1965 Jan; 36():17-20. PubMed ID: 14241913
[No Abstract] [Full Text] [Related]
14. Side effects of clofazimine therapy.
Ramu G; Iyer GG
Lepr India; 1976 Oct; 48(4 Suppl):722-31. PubMed ID: 1026810
[TBL] [Abstract][Full Text] [Related]
15. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Levis WR; Spencer TI; Ladizinski B
J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
[No Abstract] [Full Text] [Related]
16. Clofazimine-induced enteropathy in a patient of leprosy.
Singh H; Azad K; Kaur K
Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
[TBL] [Abstract][Full Text] [Related]
17. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
18. Study of toxicity of clofazimine with special reference to structural and functional status of small intestine.
Kumar B; Bahadur B; Broor SL; Kaur S; Gangwar DN; Malik AK
Lepr India; 1982 Apr; 54(2):246-55. PubMed ID: 7132294
[No Abstract] [Full Text] [Related]
19. A study of skin pigmentation by clofazimine.
Levy L; Randall HP
Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
[No Abstract] [Full Text] [Related]
20. Clofazimine pigmentation.
Pettit JH
Int J Lepr Other Mycobact Dis; 1978; 46(2):227-8. PubMed ID: 567209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
